Pharma doubles down on opioid solutions

September 28, 2017 Julie Miller

Julie Miller, Editor in Chief

On Wednesday, the President’s Commission on Combating Drug Addiction and the Opioid Crisis met for the third time in Washington, and heard from a number of drug manufacturers. For its part, the Pharmaceutical Research and Manufacturers of America (PhRMA) pledged its support for emerging opioid initiatives.

Previous Article
Flood will become CEO of Ashley in January

Gary A. Enos, Contributing EditorIn several respects, Rebecca Flood sees her move to Ashley Addiction Treat...

Next Article
Improving treatment results with Joint Commission-mandated outcome measures

Joanna L. ContiThe Joint Commission is requiring that centers systematically collect information directly f...


Have Behavioral Health Business updates sent to your inbox today!

First Name
Last Name
Thank you!
Error - something went wrong!